Efficacy and mode of action of external trigeminal neurostimulation in migraine

References

• Evers S, Áfra J, Frese A, et al. EFNS guideline on the drug treatment of migraine–revised report of an EFNS task force. Eur J Neurol. 2009;16:968–981.
   PubMed Web of Science ®Google Scholar
• Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American headache society evidence assessment of migraine pharmacotherapies. Headache. 2015;55:3–20.
   PubMed Web of Science ®Google Scholar
• Silberstein S, Latsko M, Schoenen JSJ. Preventive Antimigraine Drugs. In: Fernandez-de-las-Penas C, Chaitow L, eds. Multidisciplinary management of migraine : pharmacological, manual, and other therapies. Burlington USA: Jones & Bartlett Learning; 2013. p. 91–102.
   Google Scholar
• Lipton RB, Buse DC, Serrano D, et al. Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2013;53:1300–1311.
   PubMed Web of Science ®Google Scholar
• Paemeleire K, Magis D, Migraine SJ. Medical Treatment of migraine. In: Reference Module in Neuroscience and Biobehavioral Psychology. Elsevier; 1–5.
   Google Scholar
• Schoenen J, Magis D. Migraines and Other Headache Disorders. Lipton R, Bigal M, eds. New York: Informa Healthcare; 2006. p. 363–374.
   Google Scholar
• Gallagher RM, Kunkel R. Migraine medication attributes important for patient compliance: concerns about side effects may delay treatment. Headache. 2003;43:36–43.
   PubMed Web of Science ®Google Scholar
• Berger A, Bloudek LM, Varon SF, et al. Adherence with Migraine Prophylaxis in Clinical Practice. Pain Practice. 2012;12:541–549.
   PubMed Web of Science ®Google Scholar
• Blumenfeld AM, Bloudek LM, Becker WJ, et al. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II). Headache. 2013;53:644–655.
   PubMed Web of Science ®Google Scholar
• Turner DP, Golding AN, Houle TT. Using a graphical risk tool to examine willingness to take migraine prophylactic medications. Pain. 2016;157:2226–2234.
   PubMed Web of Science ®Google Scholar
• Hepp Z, Dodick DW, Varon SF, et al.. Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis. Cephalalgia. 2017;37:470–485.
   PubMed Web of Science ®Google Scholar
• Ahmed HE, White PF, Craig WF, et al. Use of percutaneous electrical nerve stimulation (PENS) in the short- term management of headache. Headache. 2000;40:311–315.
   PubMed Web of Science ®Google Scholar
• Ghoname EA, Craig WF, White PF. Use of percutaneous electrical nerve stimulation (PENS) for treating ECT-induced headaches. Headache. 39:502–505.
   PubMed Web of Science ®Google Scholar
• Saper JR, Dodick DW, Silberstein SD, et al. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011;31:271–285.
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Dodick DW, Saper J, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2012;32:1165–1179.
   PubMed Web of Science ®Google Scholar
• Dodick DW, Silberstein SD, Reed KL, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2015;35:344–358.
   PubMed Web of Science ®Google Scholar
• Reed KL, Black SB, Banta CJ, et al. Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial experience. Cephalalgia. 2010;30:260–271.
   PubMed Web of Science ®Google Scholar
• Schwedt TJ. Neurostimulation for primary headache disorders. Curr Neurol Neurosci Rep. 2009;9:101–107.
   PubMed Web of Science ®Google Scholar
• Schoenen J, Roberta B, Magis D, et al. Noninvasive neurostimulation methods for migraine therapy: the available evidence. Cephalalgia. 2016;36:1170–1180.
   PubMed Web of Science ®Google Scholar
• Juan Y, Shu O, Jinhe L, et al. Migraine prevention with percutaneous mastoid electrical stimulator: A randomized double-blind controlled trial. Cephalalgia. 2017;37:1248–1256.
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Calhoun AH, Lipton RB, et al.. Chronic migraine headache prevention with noninvasive vagus nerve stimulation. Neurology. 2016;87:529–538.
   PubMed Web of Science ®Google Scholar
• Yarnitsky D, Volokh L, Ironi A, et al. Nonpainful remote electrical stimulation alleviates episodic migraine pain. Neurology. 2017;88:1250–1255.
   PubMed Web of Science ®Google Scholar
• Solomon S, Guglielmo KM. Treatment of headache by transcutaneous electrical stimulation. Headache. 1985;25:12–15.
   PubMed Web of Science ®Google Scholar
• Lapeer GL. High-intensity transcutaneous nerve stimulation at the Hoku acupuncture point for relief of muscular headache pain. Literature Review Clinical Trial Cranio. 1986;4:164–171.
   Google Scholar
• Heydenreich A. [Localized transcutaneous electric nerve stimulation with high voltage impulses in functional chronic headache and migraine]. Z Arztl Fortbild (Jena). 1991;85:37–39.
   PubMedGoogle Scholar
• Taubert K. [Transcutaneous electric nerve stimulation (TENS) in headache and facial pain]. Z Arztl Fortbild (Jena). 1991;85:31–36.
   PubMedGoogle Scholar
• Russo A, Tessitore A, Conte F, et al. Transcutaneous supraorbital neurostimulation in ‘de novo’ patients with migraine without aura: the first Italian experience. J Headache Pain. 2015;16:69.
   PubMedGoogle Scholar
• Di Fiore P, Bussone G, Galli A, et al. Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial. Neurol Sci. 2017;38:201–206.
   PubMed Web of Science ®Google Scholar
• Vikelis M, Dermitzakis EV, Spingos KC, et al.. Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study. BMC Neurol. 2017;17:97.
   PubMed Web of Science ®Google Scholar
• Przeklasa-Muszyńska A, Skrzypiec K, Kocot-Kępska M, et al. Non-invasive transcutaneous Supraorbital Neurostimulation (tSNS) using Cefaly® device in prevention of primary headaches. Neurol Neurochir Pol. 2017;51:127–134.
   PubMed Web of Science ®Google Scholar
• Kozminski M. Transcutaneous supraorbital nerve stimulation as a rescue therapy. Headache. 2014;54:12.
   PubMed Web of Science ®Google Scholar
• Gérardy P, Fabry D, Fumal A, et al. A pilot study on supra-orbital surface electrotherapy in migraine. Cephalalgia. 2009;29:134.
   Google Scholar
• Schoenen J, Vandersmissen B, Jeangette S, et al. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013;80:697–704.
   PubMed Web of Science ®Google Scholar
• Bussone G, Diener HC, Pfeil J, et al.. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials. Int J Clin Pract. 2005;59:961–968.
   PubMed Web of Science ®Google Scholar
• Magis D, Sava S, d’Elia TS, et al. Safety and patients’ satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population. J Headache Pain. 2013;14: 95.
   Google Scholar
• Penning S, Schoenen J. A survey on migraine attack treatment with the CEFALY® device in regular users. Acta Neurol Belg. 2017;117:547–549.
   PubMed Web of Science ®Google Scholar
• Mann J, Schoenen J. Abortive treatment of migraine with e-TNS: pilot trial. Headache. 2018. (in press).
   Google Scholar
• Chou DE, Gross GJ, Casadei CH, et al. External Trigeminal Nerve Stimulation for the Acute Treatment of Migraine: open-Label Trial on Safety and Efficacy. Neuromodulation. 2017;20:678–683.
   PubMed Web of Science ®Google Scholar
• Chou DE, Yugrakh MS, Gross G, et al. Acute treatment of migraine with e-TNS: a multi-center, double-blind, randomized, sham-controlled trial. Cephalalgia. 2017;37:323.
   Google Scholar
• Cady RK, McAllister PJ, Spierings ELH, et al.. A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study). Headache. 2015;55:88–100.
   PubMed Web of Science ®Google Scholar
• Färkkilä M, Diener H-C, Géraud G, et al. Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study. Lancet Neurol. 2012;11:405–413.
   PubMed Web of Science ®Google Scholar
• Voss T, Lipton RB, Dodick DW, et al. A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine. Cephalalgia. 2016;36:887–898.
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Grosberg BM, Mauskop A, et al. Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study. Cephalalgia. 2014;34:986–993.
   PubMed Web of Science ®Google Scholar
• Barbanti P, Grazzi L, Egeo G, et al.. Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study. J Headache Pain. 2015;16:542.
   Web of Science ®Google Scholar
• Ersek RA. Transcutaneous electrical neurostimulation: a new therapeutic modality for controlling pain. Clin Orthop Relat Res. 1977;128:314–324.
   PubMed Web of Science ®Google Scholar
• Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971–979.
   PubMed Web of Science ®Google Scholar
• Melzack R, Wall PD. Acupuncture and transcutaneous electrical nerve stimulation. Postgrad Med J. 1984;60:893–896.
   PubMed Web of Science ®Google Scholar
• Jones I, Johnson MI. Transcutaneous electrical nerve stimulation. Contin Educ Anaesth Crit Care Pain. 2009;9:130–135.
   Google Scholar
• Schueler M, Neuhuber WL, De Col R, et al. Innervation of rat and human dura mater and pericranial tissues in the parieto-temporal region by meningeal afferents. Headache. 2014;54:996–1009.
   PubMed Web of Science ®Google Scholar
• Didier HA, Di Fiore P, Marchetti C, et al. Electromyography data in chronic migraine patients by using neurostimulation with the Cefaly® device. Neurol Sci. 2015;36(Suppl S1):115–119.
   PubMedGoogle Scholar
• Coppola G, Schoenen J. Cortical excitability in chronic migraine. Curr Pain Headache Rep. 2012;16:93–100.
   PubMed Web of Science ®Google Scholar
• Sasso D’Elia T, Fataki M, Sava S, et al. Effect of Anodal Transcranial Direct Current Stimulation Over the Visual Cortex on Thermosensitivity Assessed by Quantitative Sensory Testing and Contact Heat Evoked Potentials. Cephalalgia. 2013;33(232):P341.
   Google Scholar
• Said G, Lacroix C, Planté-Bordeneuve V, et al. Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients. Brain. 2002;125:264–275.
   PubMed Web of Science ®Google Scholar
• Jürgens TP, Busch V, Opatz O, et al. Low-frequency short-time nociceptive stimulation of the greater occipital nerve does not modulate the trigeminal system. Cephalalgia. 2008;28:842–846.
   PubMed Web of Science ®Google Scholar
• Aymanns M, Yekta SS, Ellrich J. Homotopic long-term depression of trigeminal pain and blink reflex within one side of the human face. Clin Neurophysiol. 2009;120:2093–2099.
   PubMed Web of Science ®Google Scholar
• Cruccu G, Truini A. Neurostimulation therapy (acupuncture-like) and long-term depression: a challenge for the clinical neurophysiologist. Clin Neurophysiol. 2009;120:2004–2005.
   PubMed Web of Science ®Google Scholar
• Schoenen J Scientific report. TRADONI Convention. 2014.
   Google Scholar
• Vecchio E, Gentile E, Franco G, et al. Effects of external trigeminal nerve stimulation (eTNS) on laser evoked cortical potentials (LEP): A pilot study in migraine patients and controls. Cephalalgia. 2017;33310241772874.
   Web of Science ®Google Scholar
• Piquet M, Balestra C, Sava SL, et al. Supraorbital transcutaneous neurostimulation has sedative effects in healthy subjects. BMC Neurol. 2011;11:135.
   PubMed Web of Science ®Google Scholar
• Magis D, D’Ostilio K, Thibaut A, et al. Cerebral metabolism before and after external trigeminal nerve stimulation in episodic migraine. Cephalalgia. 2017;37:881–891.
   PubMed Web of Science ®Google Scholar
• Russo A, Tessitore A, Esposito F, et al. Pain processing in patients with migraine: an event-related fMRI study during trigeminal nociceptive stimulation. J Neurol. 2012;259:1903–1912.
   PubMed Web of Science ®Google Scholar
• Russo A, Tessitore A, Esposito F, et al.. Functional Changes of the Perigenual Part of the Anterior Cingulate Cortex after External Trigeminal Neurostimulation in Migraine Patients. Front Neurol. 2017;8:282.
   PubMed Web of Science ®Google Scholar
• Coppola G, Vandenheede M, Di Climente L, et al. Somatosensory evoked high-frequency oscillations reflecting thalamo-cortical activity are decreased in migraine patients between attacks. Brain. 2004;128:98–103.
   PubMed Web of Science ®Google Scholar
• Di Lenola D, Coppola G, Serrao M, et al.. O024. Transcutaneous supraorbital nerve stimulation enhances somatosensory thalamic activity in migraine between attacks: a central mechanism of clinical efficacy?. J Headache Pain. 2015;16. Epub ahead of print. doi:10.1186/1129-2377-16-S1-A160.
   Web of Science ®Google Scholar
• Bogdanov VB, Viganò A, Noirhomme Q, et al.. Cerebral responses and role of the prefrontal cortex in conditioned pain modulation: an fMRI study in healthy subjects. Brain. 2015;281:187–198.
   Web of Science ®Google Scholar
• Matharu MS, Bartsch T, Ward N, et al. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain. 2004;127:220–230.
   PubMed Web of Science ®Google Scholar
• Fumal A, Laureys S, Di Clemente L, et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain. 2006;129:543–550.
   PubMed Web of Science ®Google Scholar
• Magis D, Bruno MA, Fumal A, et al. Central modulation in cluster headache patients treated with occipital nerve stimulation: an FDG-PET study. BMC Neurol. 2011;11: 25.
   PubMed Web of Science ®Google Scholar
• Schwedt TJ, Chiang CC, Chong CD, et al. Functional MRI of migraine. Lancet Neurology. 2015;14:81–91.
   PubMed Web of Science ®Google Scholar
• Willoch F, Gamringer U, Medele R, et al.. Analgesia by electrostimulation of the trigeminal ganglion in patients with trigeminopathic pain: a PET activation study. Pain. 2003;103:119–130.
   PubMed Web of Science ®Google Scholar
• Dai Z, Zhong J, Xiao P, et al.. Gray matter correlates of migraine and gender effect: A meta-analysis of voxel-based morphometry studies. Neuroscience. 2015;299:88–96.
   PubMed Web of Science ®Google Scholar
• Aderjan D, Stankewitz A, May A. Neuronal mechanisms during repetitive trigemino-nociceptive stimulation in migraine patients. Pain. 2010;151:97–103.
   PubMed Web of Science ®Google Scholar
• Jin C, Yuan K, Zhao L, et al. Structural and functional abnormalities in migraine patients without aura. NMR Biomed. 2013;26:58–64.
   PubMed Web of Science ®Google Scholar
• Schwedt TJ, Schlaggar BL, Mar S, et al. Atypical resting-state functional connectivity of affective pain regions in chronic migraine. Headache. 2013;53:737–751.
   PubMed Web of Science ®Google Scholar
• Xue T, Yuan K, Cheng P, et al. Alterations of regional spontaneous neuronal activity and corresponding brain circuit changes during resting state in migraine without aura. NMR Biomed. 2013;26:1051–1058.
   PubMed Web of Science ®Google Scholar
• Parkerson HA, Noel M, Pagé MG, et al. Factorial validity of the English-language version of the Pain Catastrophizing Scale--child version.. J Pain. 2013;14:1383–1389.
   PubMed Web of Science ®Google Scholar
• Yu D, Yuan K, Zhao L, et al. Regional homogeneity abnormalities affected by depressive symptoms in migraine patients without aura: a resting state study. PLoS One. 2013;8:10.
   Web of Science ®Google Scholar
• Zhao L, Liu J, Dong X, et al. Alterations in regional homogeneity assessed by fMRI in patients with migraine without aura stratified by disease duration. J Headache Pain. 2013;14:85.
   PubMed Web of Science ®Google Scholar
• Liu J, Zhao L, Li G, et al.. Hierarchical alteration of brain structural and functional networks in female migraine sufferers. PLoS One. 2012;7:10.
   Google Scholar
• Maleki N, Becerra L, Brawn J, et al.. Concurrent functional and structural cortical alterations in migraine. Cephalalgia. 2012;32:607–620.
   PubMed Web of Science ®Google Scholar
• Russo A, Tessitore A, Giordano A, et al.. Executive resting-state network connectivity in migraine without aura. Cephalalgia. 2012;32:1041–1048.
   PubMed Web of Science ®Google Scholar
• Yu D, Yuan K, Zhao L, et al. Regional homogeneity abnormalities in patients with interictal migraine without aura: a resting-state study. NMR Biomed. 2012;25:806–812.
   PubMed Web of Science ®Google Scholar
• Yuan K, Qin W, Liu P, et al. Reduced fractional anisotropy of corpus callosum modulates inter-hemispheric resting state functional connectivity in migraine patients without aura. PLoS One. 2012;7:10.
   Web of Science ®Google Scholar
• Mainero C, Boshyan J, Hadjikhani N. Altered functional magnetic resonance imaging resting-state connectivity in periaqueductal gray networks in migraine. Ann Neurol. 2011;70:838–845.
   PubMed Web of Science ®Google Scholar
• Niddam DM, Lai K-L, Tsai S-Y, et al.. Neurochemical changes in the medial wall of the brain in chronic migraine. Brain. 2017. Epub ahead of print 11 December. doi:10.1093/brain/awx331
   Web of Science ®Google Scholar
• Androulakis XM, Rorden C, Peterlin BL, et al. Modulation of salience network intranetwork resting state functional connectivity in women with chronic migraine. Cephalalgia. 2017;33310241774857.
   Google Scholar
• Faragó P, Tuka B, Tóth E, et al. Interictal brain activity differs in migraine with and without aura: resting state fMRI study. J Headache Pain. 2017;18:8.
   PubMed Web of Science ®Google Scholar
• Erk S, Meyer-Lindenberg A, Schmierer P, et al. Hippocampal and Frontolimbic Function as Intermediate Phenotype for Psychosis: evidence from Healthy Relatives and a Common Risk Variant in CACNA1C. Biological Psychiatry. 2014;76:466–475.
   PubMed Web of Science ®Google Scholar
• Enzi B, Duncan NW, Kaufmann J, et al. Glutamate modulates resting state activity in the perigenual anterior cingulate cortex - a combined fMRI-MRS study. Neuroscience. 2012;227:102–109.
   PubMed Web of Science ®Google Scholar
• Horn DI, Yu C, Steiner J, et al.. Glutamatergic and resting-state functional connectivity correlates of severity in major depression - the role of pregenual anterior cingulate cortex and anterior insula. Front Syst Neurosci. Epub ahead of print. 2010. doi:10.3389/fnsys.2010.00033.
   PubMedGoogle Scholar
• Noll-Hussong M, Otti A, Wohlschlaeger AM, et al. Neural correlates of deficits in pain-related affective meaning construction in patients with chronic pain disorder. Psychosom Med. 2013;75:124–136.
   PubMed Web of Science ®Google Scholar
• Garcia-Larrea L, Peyron R. Motor cortex stimulation for neuropathic pain: from phenomenology to mechanisms. Neuroimage. 2007;37(Suppl 1):S71–9.
   PubMed Web of Science ®Google Scholar
• Casey KL, Svensson P, Morrow TJ, et al. Selective opiate modulation of nociceptive processing in the human brain. J Neurophysiol. 2000;84:525–533.
   PubMed Web of Science ®Google Scholar
• Wagner KJ, Sprenger T, Kochs EF, et al. Imaging human cerebral pain modulation by dose-dependent opioid analgesia: a positron emission tomography activation study using remifentanil. Anesthesiology. 2007;106:548–556.
   PubMed Web of Science ®Google Scholar
• Petrovic P, et al. Placebo and opioid analgesia– imaging a shared neuronal network. Science. 2002;295:1737–1740.
   PubMed Web of Science ®Google Scholar
• Sprenger T, Ruether K, Boecker H, et al. Altered Metabolism in Frontal Brain Circuits in Cluster Headache. Cephalalgia. 2007;27:1033–1042.
   PubMed Web of Science ®Google Scholar
• Sprenger T, Willoch F, Miederer M, et al. Opioidergic changes in the pineal gland and hypothalamus in cluster headache: a ligand PET study. Neurology. 2006;66:1108–1110.
   PubMed Web of Science ®Google Scholar
• May A, Bahra A, Büchel C, et al. Hypothalamic activation in cluster headache attacks. Lancet. 1998;352:275–278.
   PubMed Web of Science ®Google Scholar
• Schulte LH, May A. The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016;139:1987–1993.
   PubMed Web of Science ®Google Scholar
• Boehringer A, Tost H, Haddad L, et al. Neural Correlates of the Cortisol Awakening Response in Humans. Neuropsychopharmacology. 2015;40:2278–2285.
   PubMed Web of Science ®Google Scholar
• Mousavi SA, Mirbod SM, Khorvash F. Comparison between efficacy of imipramine and transcutaneous electrical nerve stimulation in the prophylaxis of chronic tension-type headache: a randomized controlled clinical trial. J Res Med Sci. 2011;16:923–927.
   PubMed Web of Science ®Google Scholar
• Plazier M, Dekelver I, Vanneste S, et al.. Occipital nerve stimulation in fibromyalgia: a double-blind placebo-controlled pilot study with a six-month follow-up. Neuromodulation. 2014;17:256–63–4.
   PubMed Web of Science ®Google Scholar
• Cook IA, Abrams M, Leuchter AF. Trigeminal Nerve Stimulation for Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder. Neuromodulation. 2016;19:299–305.
   PubMed Web of Science ®Google Scholar
• DeGiorgio CM, Soss J, Cook IA, et al. Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy. Neurology. 2013;80:786–791.
   PubMed Web of Science ®Google Scholar
• Sava S, Cosseddu A, D’Ostilio K, et al. Anodal transcranial direct stimulation (tDCS) targeting the anterior cingulate gyrus for the preventive treatment of chronic cluster headache: a proof-of-concept trial. Cephalalgia. 2015;35: 91.
   Web of Science ®Google Scholar